KindredBio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

SAN FRANCISCO, California. (May 21, 2014) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will participate in the 11th Annual Craig-Hallum Institutional Investor Conference in Minneapolis on May 28th. KindredBio will present at the Stifel Dental and Veterinary Conference on May 28th and the Jefferies Global Healthcare Conference on June 2nd, both in New York City. Details for the presentations are below:

Read more

KindredBio to Present at Needham 13th Annual Healthcare Conference

SAN FRANCISCO, California. (April 4, 2014) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will present at Needham 13th Annual Healthcare Conference in New York City:

Read more

KindredBio to Present at Roth Capital Partners 26th Annual Growth Stock Conference

SAN FRANCISCO, California. (March 4, 2014) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will present at Roth Capital Partners 26th Annual Growth Stock Conference in Dana Point, CA:

Read more

KindredBio to Present at 2014 Leerink Global Healthcare Conference

SAN FRANCISCO, California. (February 6, 2014) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that members of its senior management team will participate in a fireside chat presentation at the 2014 Leerink Global Healthcare Conference in New York City:

Read more